VOYA Investment Management
VERA icon

VOYA Investment Management’s Vera Therapeutics VERA Stock Holding History

VOYA Investment Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.6M Buy
642,562
+352,086
+121% +$13.1M 0.02% 433
2026
Q1 		$11.7M Sell
290,476
-128,487
-31% -$5.54M 0.01% 574
2025
Q4 		$21.2M Buy
418,963
+2,587
+0.6% +$91.9K 0.02% 497
2025
Q3 		$12.1M Sell
416,376
-11,563
-3% -$267K 0.01% 614
2025
Q2 		$10.1M Sell
427,939
-199,418
-32% -$4.48M 0.01% 729
2025
Q1 		$15.1M Sell
627,357
-67,734
-10% -$2.18M 0.02% 620
2024
Q4 		$29.4M Buy
695,091
+591,682
+572% +$26.2M 0.03% 431
2024
Q3 		$4.57M Sell
103,409
-316
-0.3% -$12K ﹤0.01% 1037
2024
Q2 		$3.75M Buy
103,725
+1,561
+2% +$61.9K ﹤0.01% 1120
2024
Q1 		$4.41M Buy
102,164
+88,402
+642% +$3.15M ﹤0.01% 1057
2023
Q4 		$212K Hold
13,762
– – ﹤0.01% 2559
2023
Q3 		$189K Buy
13,762
+284
+2% +$4.87K ﹤0.01% 2572
2023
Q2 		$216K Buy
+13,478
New +$122K ﹤0.01% 2547

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

VOYA Investment Management's VERA Position: Q2 2026 in Review

VOYA Investment Management increased its Vera Therapeutics (VERA) stake by 121% in Q2 2026, buying an estimated $13.1M and bringing the position to 642,562 shares worth $27.6M. The position accounts for 0.02% of the portfolio, ranked #433.

VOYA Investment Management first reported a position in VERA in Q2 2023 and has held it in 13 quarters since. The position peaked at $29.4M in Q4 2024. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • VOYA Investment Management held 642,562 shares of Vera Therapeutics worth $27.6M as of Q2 2026.
  • VOYA Investment Management bought 352,086 Vera Therapeutics shares in Q2 2026, an estimated $13.1M.
  • Vera Therapeutics made up 0.02% of VOYA Investment Management's portfolio in Q2 2026, its #433 holding.
  • VOYA Investment Management first reported a position in Vera Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • VOYA Investment Management's Vera Therapeutics position peaked at $29.4M in Q4 2024.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.